Carregant...

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas

Genetic and/or epigenetic changes provide antigen-derived diversity in neoplastic cells. Beside, these cells do not initiate immune response of host organisms. A variety of factors are responsible for the resistant to treatment, including individual variations in patients and somatic cell genetic di...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Magdalena Witkowska, Piotr Smolewski
Format: Artigo
Idioma:Inglês
Publicat: Wiley 2018-01-01
Col·lecció:Journal of Immunology Research
Accés en línia:http://dx.doi.org/10.1155/2018/1982423
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!